Denosumab in castration-resistant prostate cancer.
Lancet
; 379(9828): e50; author reply e50-1, 2012 May 12.
Article
in En
| MEDLINE
| ID: mdl-22579323
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Bone Neoplasms
/
Orchiectomy
/
RANK Ligand
/
Antibodies, Monoclonal
Limits:
Humans
/
Male
Language:
En
Journal:
Lancet
Year:
2012
Document type:
Article